Skip to main content

Piet Wigerinck

Premium
Galapagos has appointed Piet Wigerinck as senior vice president of development, the company announced this week.
 
Wigerinck joins Galapagos from Tibotec, where he was vice president for drug discovery, early development, and chemistry manufacturing and control, and a member of the management board. Prior to Tibotec, Wigerinck was a medicinal chemist at Janssen Research Foundation

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.